Impact of monocytic differentiation on acute myeloid leukemia patients treated with venetoclax and hypomethylating agents

Abstract Introduction Although the combination of venetoclax (VEN) and hypomethylating agents (HMAs) results in impressive efficacy in acute myeloid leukemia (AML), there is still a subset of patients who are refractory. We investigated the outcomes of AML patients with monocytic differentiation who...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Dian Jin, Jingsong He, Haoguang Chen, Wenjun Wu, Xiaoyan Han, Jing Le, Wenxiu Shu, Qianqian Yang, Shanshan Pei, Zhen Cai, Donghua He
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2024-07-01
Colecção:	Cancer Medicine
Assuntos:	acute myeloid leukemia cancer risk factor prognosis targeted therapy
Acesso em linha:	https://doi.org/10.1002/cam4.7378
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!